Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.

Caduff, Nicole; McHugh, Donal; Murer, Anita; Rämer, Patrick; Raykova, Ana; Landtwing, Vanessa; Rieble, Lisa; Keller, Christian W; Prummer, Michael; Hoffmann, Laurent; Lam, Janice K P; Chiang, Alan K S; Raulf, Friedrich; Azzi, Tarik; Berger, Christoph; Rubic-Schneider, Tina; Traggiai, Elisabetta; Lünemann, Jan D; Kammüller, Michael; Münz, Christian

Caduff, Nicole; McHugh, Donal; Murer, Anita; Rämer, Patrick; Raykova, Ana; Landtwing, Vanessa; Rieble, Lisa; Keller, Christian W; Prummer, Michael; Hoffmann, Laurent; Lam, Janice K P; Chiang, Alan K S; Raulf, Friedrich; Azzi, Tarik; Berger, Christoph; Rubic-Schneider, Tina; Traggiai, Elisabetta; Lünemann, Jan D; Kammüller, Michael; Münz, Christian.

PLoS Pathog ; 16(12): e1009167, 2020 Dec.

Article en En | MEDLINE | ID: mdl-33347498

ABSTRACT

ABSTRACT

[This corrects the article DOI 10.1371/journal.ppat.1008477.].

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: PLoS Pathog Año: 2020 Tipo del documento: Article